Find latest Non-Small Cell Lung Cancer videos
·
500+ videos
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Treatment Approach to ROS1 Rearranged NSCLC
By
Yale Cancer Center
FEATURING
Michael Grant
By
Yale Cancer Center
FEATURING
Michael Grant
525 views
October 19, 2023
On November 15, 2023, the FDA approved repotrectinib (brand name Augtyro) for locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Comments 0
Login to view comments.
Click here to Login